The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable for Cosmetic Surgery Market Research Report 2025
Synopsis
Cosmetic surgery is a process that enhances or alters a portion of an individual’s body, or, face through incision. Cosmetic surgeries include reconstruction or reshaping of body parts, altering facial structure (maxillofacial), altering structure of jaw (craniofacial), etc. People from urban areas constitute the largest patient base for cosmetic surgeries due to increased aesthetic appeal.
The global Injectable for Cosmetic Surgery market was valued at US$ 45840 million in 2023 and is anticipated to reach US$ 173000 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable for Cosmetic Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable for Cosmetic Surgery.
Report Scope
The Injectable for Cosmetic Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable for Cosmetic Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable for Cosmetic Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
HUGEL
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Q.O.Fill (JW Pharmaceutical)
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Matex-Lab
Jingjia Medical
Genoss
Bohus BioTech
Caregen
Segment by Type
Botulinum Toxin
Soft Tissue Fillers
Dermal Fillers
Others
Segment by Application
Hospitals
Dermatology Clinics
Beauty Centers
Othes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable for Cosmetic Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cosmetic surgery is a process that enhances or alters a portion of an individual’s body, or, face through incision. Cosmetic surgeries include reconstruction or reshaping of body parts, altering facial structure (maxillofacial), altering structure of jaw (craniofacial), etc. People from urban areas constitute the largest patient base for cosmetic surgeries due to increased aesthetic appeal.
The global Injectable for Cosmetic Surgery market was valued at US$ 45840 million in 2023 and is anticipated to reach US$ 173000 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Injectable for Cosmetic Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable for Cosmetic Surgery.
Report Scope
The Injectable for Cosmetic Surgery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable for Cosmetic Surgery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable for Cosmetic Surgery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
HUGEL
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Q.O.Fill (JW Pharmaceutical)
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Matex-Lab
Jingjia Medical
Genoss
Bohus BioTech
Caregen
Segment by Type
Botulinum Toxin
Soft Tissue Fillers
Dermal Fillers
Others
Segment by Application
Hospitals
Dermatology Clinics
Beauty Centers
Othes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable for Cosmetic Surgery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable for Cosmetic Surgery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Botulinum Toxin
1.2.3 Soft Tissue Fillers
1.2.4 Dermal Fillers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable for Cosmetic Surgery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Beauty Centers
1.3.5 Othes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable for Cosmetic Surgery Market Perspective (2019-2030)
2.2 Injectable for Cosmetic Surgery Growth Trends by Region
2.2.1 Global Injectable for Cosmetic Surgery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable for Cosmetic Surgery Historic Market Size by Region (2019-2024)
2.2.3 Injectable for Cosmetic Surgery Forecasted Market Size by Region (2025-2030)
2.3 Injectable for Cosmetic Surgery Market Dynamics
2.3.1 Injectable for Cosmetic Surgery Industry Trends
2.3.2 Injectable for Cosmetic Surgery Market Drivers
2.3.3 Injectable for Cosmetic Surgery Market Challenges
2.3.4 Injectable for Cosmetic Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable for Cosmetic Surgery Players by Revenue
3.1.1 Global Top Injectable for Cosmetic Surgery Players by Revenue (2019-2024)
3.1.2 Global Injectable for Cosmetic Surgery Revenue Market Share by Players (2019-2024)
3.2 Global Injectable for Cosmetic Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable for Cosmetic Surgery Revenue
3.4 Global Injectable for Cosmetic Surgery Market Concentration Ratio
3.4.1 Global Injectable for Cosmetic Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable for Cosmetic Surgery Revenue in 2023
3.5 Injectable for Cosmetic Surgery Key Players Head office and Area Served
3.6 Key Players Injectable for Cosmetic Surgery Product Solution and Service
3.7 Date of Enter into Injectable for Cosmetic Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable for Cosmetic Surgery Breakdown Data by Type
4.1 Global Injectable for Cosmetic Surgery Historic Market Size by Type (2019-2024)
4.2 Global Injectable for Cosmetic Surgery Forecasted Market Size by Type (2025-2030)
5 Injectable for Cosmetic Surgery Breakdown Data by Application
5.1 Global Injectable for Cosmetic Surgery Historic Market Size by Application (2019-2024)
5.2 Global Injectable for Cosmetic Surgery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable for Cosmetic Surgery Market Size (2019-2030)
6.2 North America Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
6.4 North America Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable for Cosmetic Surgery Market Size (2019-2030)
7.2 Europe Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
7.4 Europe Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable for Cosmetic Surgery Market Size (2019-2030)
8.2 Asia-Pacific Injectable for Cosmetic Surgery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable for Cosmetic Surgery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable for Cosmetic Surgery Market Size (2019-2030)
9.2 Latin America Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
9.4 Latin America Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable for Cosmetic Surgery Market Size (2019-2030)
10.2 Middle East & Africa Injectable for Cosmetic Surgery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable for Cosmetic Surgery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Injectable for Cosmetic Surgery Introduction
11.1.4 AbbVie Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Galderma
11.2.1 Galderma Company Detail
11.2.2 Galderma Business Overview
11.2.3 Galderma Injectable for Cosmetic Surgery Introduction
11.2.4 Galderma Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.2.5 Galderma Recent Development
11.3 LG Life Sciences
11.3.1 LG Life Sciences Company Detail
11.3.2 LG Life Sciences Business Overview
11.3.3 LG Life Sciences Injectable for Cosmetic Surgery Introduction
11.3.4 LG Life Sciences Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.3.5 LG Life Sciences Recent Development
11.4 Merz
11.4.1 Merz Company Detail
11.4.2 Merz Business Overview
11.4.3 Merz Injectable for Cosmetic Surgery Introduction
11.4.4 Merz Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.4.5 Merz Recent Development
11.5 Medytox
11.5.1 Medytox Company Detail
11.5.2 Medytox Business Overview
11.5.3 Medytox Injectable for Cosmetic Surgery Introduction
11.5.4 Medytox Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.5.5 Medytox Recent Development
11.6 HUGEL
11.6.1 HUGEL Company Detail
11.6.2 HUGEL Business Overview
11.6.3 HUGEL Injectable for Cosmetic Surgery Introduction
11.6.4 HUGEL Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.6.5 HUGEL Recent Development
11.7 Croma-Pharma
11.7.1 Croma-Pharma Company Detail
11.7.2 Croma-Pharma Business Overview
11.7.3 Croma-Pharma Injectable for Cosmetic Surgery Introduction
11.7.4 Croma-Pharma Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.7.5 Croma-Pharma Recent Development
11.8 Beijing IMEIK
11.8.1 Beijing IMEIK Company Detail
11.8.2 Beijing IMEIK Business Overview
11.8.3 Beijing IMEIK Injectable for Cosmetic Surgery Introduction
11.8.4 Beijing IMEIK Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.8.5 Beijing IMEIK Recent Development
11.9 Bloomage Bio
11.9.1 Bloomage Bio Company Detail
11.9.2 Bloomage Bio Business Overview
11.9.3 Bloomage Bio Injectable for Cosmetic Surgery Introduction
11.9.4 Bloomage Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.9.5 Bloomage Bio Recent Development
11.10 Elravie (Humedix)
11.10.1 Elravie (Humedix) Company Detail
11.10.2 Elravie (Humedix) Business Overview
11.10.3 Elravie (Humedix) Injectable for Cosmetic Surgery Introduction
11.10.4 Elravie (Humedix) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.10.5 Elravie (Humedix) Recent Development
11.11 Cleviel (Pharma Research Products)
11.11.1 Cleviel (Pharma Research Products) Company Detail
11.11.2 Cleviel (Pharma Research Products) Business Overview
11.11.3 Cleviel (Pharma Research Products) Injectable for Cosmetic Surgery Introduction
11.11.4 Cleviel (Pharma Research Products) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.11.5 Cleviel (Pharma Research Products) Recent Development
11.12 Haohai Biological
11.12.1 Haohai Biological Company Detail
11.12.2 Haohai Biological Business Overview
11.12.3 Haohai Biological Injectable for Cosmetic Surgery Introduction
11.12.4 Haohai Biological Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.12.5 Haohai Biological Recent Development
11.13 Q.O.Fill (JW Pharmaceutical)
11.13.1 Q.O.Fill (JW Pharmaceutical) Company Detail
11.13.2 Q.O.Fill (JW Pharmaceutical) Business Overview
11.13.3 Q.O.Fill (JW Pharmaceutical) Injectable for Cosmetic Surgery Introduction
11.13.4 Q.O.Fill (JW Pharmaceutical) Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.13.5 Q.O.Fill (JW Pharmaceutical) Recent Development
11.14 Teoxane
11.14.1 Teoxane Company Detail
11.14.2 Teoxane Business Overview
11.14.3 Teoxane Injectable for Cosmetic Surgery Introduction
11.14.4 Teoxane Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.14.5 Teoxane Recent Development
11.15 Sinclair
11.15.1 Sinclair Company Detail
11.15.2 Sinclair Business Overview
11.15.3 Sinclair Injectable for Cosmetic Surgery Introduction
11.15.4 Sinclair Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.15.5 Sinclair Recent Development
11.16 Suneva Medical
11.16.1 Suneva Medical Company Detail
11.16.2 Suneva Medical Business Overview
11.16.3 Suneva Medical Injectable for Cosmetic Surgery Introduction
11.16.4 Suneva Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.16.5 Suneva Medical Recent Development
11.17 CG Bio
11.17.1 CG Bio Company Detail
11.17.2 CG Bio Business Overview
11.17.3 CG Bio Injectable for Cosmetic Surgery Introduction
11.17.4 CG Bio Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.17.5 CG Bio Recent Development
11.18 SciVision Biotech
11.18.1 SciVision Biotech Company Detail
11.18.2 SciVision Biotech Business Overview
11.18.3 SciVision Biotech Injectable for Cosmetic Surgery Introduction
11.18.4 SciVision Biotech Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.18.5 SciVision Biotech Recent Development
11.19 Prollenium
11.19.1 Prollenium Company Detail
11.19.2 Prollenium Business Overview
11.19.3 Prollenium Injectable for Cosmetic Surgery Introduction
11.19.4 Prollenium Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.19.5 Prollenium Recent Development
11.20 Matex-Lab
11.20.1 Matex-Lab Company Detail
11.20.2 Matex-Lab Business Overview
11.20.3 Matex-Lab Injectable for Cosmetic Surgery Introduction
11.20.4 Matex-Lab Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.20.5 Matex-Lab Recent Development
11.21 Jingjia Medical
11.21.1 Jingjia Medical Company Detail
11.21.2 Jingjia Medical Business Overview
11.21.3 Jingjia Medical Injectable for Cosmetic Surgery Introduction
11.21.4 Jingjia Medical Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.21.5 Jingjia Medical Recent Development
11.22 Genoss
11.22.1 Genoss Company Detail
11.22.2 Genoss Business Overview
11.22.3 Genoss Injectable for Cosmetic Surgery Introduction
11.22.4 Genoss Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.22.5 Genoss Recent Development
11.23 Bohus BioTech
11.23.1 Bohus BioTech Company Detail
11.23.2 Bohus BioTech Business Overview
11.23.3 Bohus BioTech Injectable for Cosmetic Surgery Introduction
11.23.4 Bohus BioTech Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.23.5 Bohus BioTech Recent Development
11.24 Caregen
11.24.1 Caregen Company Detail
11.24.2 Caregen Business Overview
11.24.3 Caregen Injectable for Cosmetic Surgery Introduction
11.24.4 Caregen Revenue in Injectable for Cosmetic Surgery Business (2019-2024)
11.24.5 Caregen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
